Lacticaseibacillus paracasei GM-080 Ameliorates Allergic Airway Inflammation in Children with Allergic Rhinitis: From an Animal Model to a Double-Blind, Randomized, Placebo-Controlled Trial

被引:17
|
作者
Lin, En-Kwang [1 ,2 ]
Chang, Wen-Wei [3 ,4 ]
Jhong, Jhih-Hua [5 ]
Tsai, Wan-Hua [6 ]
Chou, Chia-Hsuan [6 ]
Wang, I-Jen [7 ,8 ,9 ,10 ]
机构
[1] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei 112304, Taiwan
[2] Taipei Med Univ, Wanfang Hosp, Dept Surg, Div Colorectal Surg, Taipei 110301, Taiwan
[3] Chung Shan Med Univ, Sch Biomed Sci, Taichung, Taiwan
[4] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan
[5] Hsinchu MacKay Mem Hosp, Dept Med Res, Hsinchu, Taiwan
[6] GenMont Biotech Inc, Res & Dev Dept, Tainan, Taiwan
[7] Taipei Hosp, Dept Pediat, Minist Hlth & Welf, New Taipei 242033, Taiwan
[8] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei 112304, Taiwan
[9] China Med Univ, Coll Publ Hlth, Taichung, Taiwan
[10] Taipei Hosp, Dept Pediat, Minist Hlth & Welf, 127 Su-Yuan Rd, Miaoli, Taiwan
关键词
allergic airway inflammation; animal model; allergic rhinitis; clinical trial; probiotics; MUCUS PRODUCTION; PROBIOTICS; GENOME; RESPONSES; HISTORY; MICE; DNA;
D O I
10.3390/cells12050768
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Probiotics may facilitate the clinical management of allergic diseases. However, their effects on allergic rhinitis (AR) remain unclear. We examined the efficacy and safety of Lacticaseibacillus paracasei GM-080 in a mouse model of airway hyper-responsiveness (AHR) and in children with perennial AR (PAR) by using a double-blind, prospective, randomized, placebo-controlled design. Methods: The production of interferon (IFN)-gamma and interleukin (IL)-12 was measured by using an enzyme-linked immunosorbent assay. GM-080 safety was evaluated via the whole-genome sequencing (WGS) of virulence genes. An ovalbumin (OVA)-induced AHR mouse model was constructed, and lung inflammation was evaluated by measuring the infiltrating leukocyte content of bronchoalveolar lavage fluid. A clinical trial was conducted with 122 children with PAR who were randomized to receive different doses of GM-080 or the placebo for 3 months, and their AHR symptom severity scores, total nasal symptom scores (TNSSs), and Investigator Global Assessment Scale scores were examined. Results: Among the tested L. paracasei strains, GM-080 induced the highest IFN-gamma and IL-12 levels in mouse splenocytes. WGS analysis revealed the absence of virulence factors or antibiotic-resistance genes in GM-080. The oral administration of GM-080 at 1 x 10(7) colony forming units (CFU)/mouse/day for 8 weeks alleviated OVA-induced AHR and reduced airway inflammation in mice. In children with PAR, the oral consumption of GM-080 at 2 x 10(9) CFU/day for 3 months ameliorated sneezing and improved Investigator Global Assessment Scale scores significantly. GM-080 consumption led to a nonsignificant decrease in TNSS and also nonsignificantly reduced IgE but increased INF-gamma levels. Conclusion: GM-080 may be used as a nutrient supplement to alleviate airway allergic inflammation.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study)
    Costal, D. J.
    Marteau, P.
    Amouyall, M.
    Poulsen, L. K.
    Hamelmann, E.
    Cazaubie, M., I
    Housez, B.
    Leuillet, S.
    Stavnsbjere, M.
    Molimard, P.
    Courau, S.
    Bousquet, J.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2014, 68 (05) : 602 - 607
  • [42] A DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF INTERVENT BEDDING SYSTEM IN PERENNIAL ALLERGIC RHINITIS
    HOWARTH, PH
    LUNN, A
    TOMKINS, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (01) : 305 - 305
  • [43] Brompheniramine maleate: A double-blind, placebo-controlled comparison with terfenadine for symptoms of allergic rhinitis
    Thoden, WR
    Druce, HM
    Furey, SA
    Lockhart, EA
    Ratner, P
    Hampel, FC
    van Bavel, J
    AMERICAN JOURNAL OF RHINOLOGY, 1998, 12 (04): : 293 - 299
  • [44] Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study)
    D J Costa
    P Marteau
    M Amouyal
    L K Poulsen
    E Hamelmann
    M Cazaubiel
    B Housez
    S Leuillet
    M Stavnsbjerg
    P Molimard
    S Courau
    J Bousquet
    European Journal of Clinical Nutrition, 2014, 68 : 602 - 607
  • [45] Loratadine-pseudoephedrine in children with allergic rhinitis, a controlled double-blind trial
    Serra, HA
    Alves, O
    Rizzo, LFL
    Devoto, FM
    Ascierto, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (02) : 147 - 150
  • [46] Double-Blind, Placebo-Controlled (DBPC) Trial of Oral Immunotherapy (OIT) in Peanut Allergic Children
    Jones, S. M.
    Scurlock, A. M.
    Pons, L.
    Kulis, M.
    Perry, T. T.
    Steele, P.
    Kamilaris, J.
    Henry, K. A.
    Burks, A. W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S211 - S211
  • [47] Montelukast in the treatment of nighttime symptoms associated with seasonal allergic rhinitis in double-blind, randomized, placebo-controlled studies
    Philip, G
    Meltzer, EO
    Malmstrom, K
    Marchal, JL
    Reiss, TF
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S105 - S105
  • [48] Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study
    Yamamoto, Hideyuki
    Yamada, Takechiyo
    Kubo, Seita
    Osawa, Yoko
    Kimura, Yuichi
    Oh, Myonmi
    Susuki, Dai
    Takabayashi, Tetsuji
    Okamoto, Masayuki
    Fujieda, Shigeharu
    ALLERGY AND ASTHMA PROCEEDINGS, 2010, 31 (04) : 296 - 303
  • [49] Preventive effect of nasal filters on allergic rhinitis: A randomized, double-blind, placebo-controlled crossover park study
    Kenney, Peter
    Hilberg, Ole
    Laursen, Anne Cathrine
    Peel, Robert George
    Sigsgaard, Torben
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (06) : 1566 - U213
  • [50] A randomized, double-blind placebo-controlled study of intranasal standardized cinnamon bark extract for seasonal allergic rhinitis
    Steels, Eleanor
    Steels, Elizabeth
    Deshpande, Pallavi
    Thakurdesai, Prasad
    Dighe, Satish
    Collet, Trudi
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 47